These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 8403793

  • 1. Effect of glucocorticosteroid treatment on beta-adrenoceptor subtype function in adipocytes from patients with asthma.
    Reynisdottir S, Wahrenberg H, Bylin G, Arner P.
    Clin Sci (Lond); 1993 Aug; 85(2):237-44. PubMed ID: 8403793
    [Abstract] [Full Text] [Related]

  • 2. Noradrenaline-induced lipolysis in isolated mesenteric, omental and subcutaneous adipocytes from obese subjects.
    Van Harmelen V, Lönnqvist F, Thörne A, Wennlund A, Large V, Reynisdottir S, Arner P.
    Int J Obes Relat Metab Disord; 1997 Nov; 21(11):972-9. PubMed ID: 9368819
    [Abstract] [Full Text] [Related]

  • 3. Adipocyte lipolysis in normal weight subjects with obesity among first-degree relatives.
    Hellström L, Langin D, Reynisdottir S, Dauzats M, Arner P.
    Diabetologia; 1996 Aug; 39(8):921-8. PubMed ID: 8858214
    [Abstract] [Full Text] [Related]

  • 4. Demonstration of an in vivo functional beta 3-adrenoceptor in man.
    Enocksson S, Shimizu M, Lönnqvist F, Nordenström J, Arner P.
    J Clin Invest; 1995 May; 95(5):2239-45. PubMed ID: 7738189
    [Abstract] [Full Text] [Related]

  • 5. Catecholamine-induced adipocyte lipolysis in human hyperthyroidism.
    Hellström L, Wahrenberg H, Reynisdottir S, Arner P.
    J Clin Endocrinol Metab; 1997 Jan; 82(1):159-66. PubMed ID: 8989252
    [Abstract] [Full Text] [Related]

  • 6. Regulation of lipolysis in fat cells of obese women during long-term hypocaloric diet.
    Hellström L, Reynisdottir S, Langin D, Rössner S, Arner P.
    Int J Obes Relat Metab Disord; 1996 Aug; 20(8):745-52. PubMed ID: 8856398
    [Abstract] [Full Text] [Related]

  • 7. Lipolytic catecholamine resistance linked to alpha 2-adrenoceptor sensitivity--a metabolic predictor of weight loss in obese subjects.
    Hellström L, Rössner S, Hagström-Toft E, Reynisdottir S.
    Int J Obes Relat Metab Disord; 1997 Apr; 21(4):314-20. PubMed ID: 9130030
    [Abstract] [Full Text] [Related]

  • 8. Determination of beta 3-adrenoceptor mediated lipolysis in human fat cells.
    Hoffstedt J, Shimizu M, Sjöstedt S, Lönnqvist F.
    Obes Res; 1995 Sep; 3(5):447-57. PubMed ID: 8521164
    [Abstract] [Full Text] [Related]

  • 9. Variation in adrenergic regulation of lipolysis between omental and subcutaneous adipocytes from obese and non-obese men.
    Hoffstedt J, Arner P, Hellers G, Lönnqvist F.
    J Lipid Res; 1997 Apr; 38(4):795-804. PubMed ID: 9144094
    [Abstract] [Full Text] [Related]

  • 10. Lipolytic catecholamine resistance due to decreased beta 2-adrenoceptor expression in fat cells.
    Lönnqvist F, Wahrenberg H, Hellström L, Reynisdottir S, Arner P.
    J Clin Invest; 1992 Dec; 90(6):2175-86. PubMed ID: 1334970
    [Abstract] [Full Text] [Related]

  • 11. The effect of the beta(2) adrenoceptor gene Thr164Ile polymorphism on human adipose tissue lipolytic function.
    Hoffstedt J, Iliadou A, Pedersen NL, Schalling M, Arner P.
    Br J Pharmacol; 2001 Jul; 133(5):708-12. PubMed ID: 11429395
    [Abstract] [Full Text] [Related]

  • 12. In situ assessment of the role of the beta 1-, beta 2- and beta 3-adrenoceptors in the control of lipolysis and nutritive blood flow in human subcutaneous adipose tissue.
    Barbe P, Millet L, Galitzky J, Lafontan M, Berlan M.
    Br J Pharmacol; 1996 Mar; 117(5):907-13. PubMed ID: 8851509
    [Abstract] [Full Text] [Related]

  • 13. Mechanisms for differences in lipolysis between human subcutaneous and omental fat cells.
    Hellmér J, Marcus C, Sonnenfeld T, Arner P.
    J Clin Endocrinol Metab; 1992 Jul; 75(1):15-20. PubMed ID: 1320047
    [Abstract] [Full Text] [Related]

  • 14. Effect of the (C825T) Gbeta(3) polymorphism on adrenoceptor-mediated lipolysis in human fat cells.
    Rydén M, Faulds G, Hoffstedt J, Wennlund A, Arner P.
    Diabetes; 2002 May; 51(5):1601-8. PubMed ID: 11978662
    [Abstract] [Full Text] [Related]

  • 15. Evidence for a functional beta 3-adrenoceptor in man.
    Lönnqvist F, Krief S, Strosberg AD, Nyberg S, Emorine LJ, Arner P.
    Br J Pharmacol; 1993 Nov; 110(3):929-36. PubMed ID: 7905344
    [Abstract] [Full Text] [Related]

  • 16. A pathogenic role of visceral fat beta 3-adrenoceptors in obesity.
    Lönnqvist F, Thöme A, Nilsell K, Hoffstedt J, Arner P.
    J Clin Invest; 1995 Mar; 95(3):1109-16. PubMed ID: 7883959
    [Abstract] [Full Text] [Related]

  • 17. Normal responsiveness of superficial hand veins to alpha- and beta-adrenergic stimuli in allergic asthma: effects of terbutaline and prednisolone on beta-adrenergic responsiveness.
    Eichler HG, Blöchl-Daum B, Eichler I, Wolzt M, Korn A, Götz M.
    J Allergy Clin Immunol; 1990 Nov; 86(5):714-25. PubMed ID: 1977786
    [Abstract] [Full Text] [Related]

  • 18. Beta-adrenoceptor subtype expression and function in rat white adipocytes.
    Germack R, Starzec AB, Vassy R, Perret GY.
    Br J Pharmacol; 1997 Jan; 120(2):201-10. PubMed ID: 9117110
    [Abstract] [Full Text] [Related]

  • 19. Effect of glucocorticosteroid treatment on glucocorticoid receptor expression in human adipocytes.
    Brönnegård M, Reynisdottir S, Marcus C, Stierna P, Arner P.
    J Clin Endocrinol Metab; 1995 Dec; 80(12):3608-12. PubMed ID: 8530607
    [Abstract] [Full Text] [Related]

  • 20. Simulated microgravity increases beta-adrenergic lipolysis in human adipose tissue.
    Barbe P, Galitzky J, De Glisezinski I, Riviere D, Thalamas C, Senard JM, Crampes F, Lafontan M, Berlan M.
    J Clin Endocrinol Metab; 1998 Feb; 83(2):619-25. PubMed ID: 9467583
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.